Quarterly Transactions Made in Xeris Biopharma Holdings, Inc. (XERS)
This table provides information about the institutional ownership of Xeris Biopharma Holdings, Inc. (XERS). The information is specifically focused on institutions that hold shares of Xeris Biopharma Holdings, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2022 | 2,791,700 | 622,056 | 3,413,756 | 4,272,413 | 66,540 | 4,338,953 | -925,197 | |
| Q4 2022 | 986,939 | 1,639,183 | 2,626,122 | 2,573,804 | 0 | 2,573,804 | 52,318 | |
| Q1 2023 | 2,196,598 | 1,002,304 | 3,198,902 | 3,324,390 | 60,000 | 3,384,390 | -185,488 | |
| Q2 2023 | 2,965,197 | 9,716,622 | 12,681,819 | 5,504,422 | 0 | 5,504,422 | 7,177,397 | |
| Q3 2023 | 2,134,895 | 7,918,711 | 10,053,606 | 4,935,119 | 0 | 4,935,119 | 5,118,487 | |
| Q4 2023 | 4,012,085 | 1,480,430 | 5,492,515 | 3,701,832 | 0 | 3,701,832 | 1,790,683 | |
| Q1 2024 | 7,103,567 | 3,004,269 | 10,107,836 | 10,420,984 | 0 | 10,420,984 | -313,148 | |
| Q2 2024 | 4,027,185 | 304,440 | 4,331,625 | 4,159,375 | 0 | 4,159,375 | 172,250 | |
| Q3 2024 | 7,082,384 | 4,478,014 | 11,560,398 | 2,607,107 | 0 | 2,607,107 | 8,953,291 | |
| Q4 2024 | 7,175,115 | 3,163,070 | 10,338,185 | 8,019,296 | 0 | 8,019,296 | 2,318,889 | |
| Q1 2025 | 21,752,831 | 9,476,218 | 31,229,049 | 2,321,347 | 0 | 2,321,347 | 28,907,702 | |
| Q2 2025 | 12,788,280 | 1,301,220 | 14,089,500 | 6,942,421 | 0 | 6,942,421 | 7,147,079 | |
| Q3 2025 | 13,162,126 | 4,314,321 | 17,476,447 | 9,131,168 | 80 | 9,131,248 | 8,345,199 | |